Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer

• Publication date

  2010-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cncr.25184PMID 20564627
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Renal tumors].

  2011cited by this paper
• Re: Renal mass biopsy--a renaissance? B. R. Lane, M. K. Samplaski, B. R. Herts, M. Zhou, A. C. Novick and S. C. Campbell J Urol 2008; 179: 20-27.

  2009cited by this paper
• Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?

  2009cited by this paper
• Cryoablation for renal tumors: current status

  2009cited by this paper
• Active surveillance of renal masses in elderly patients.

  2008cited by this paper
• Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians?

  2008cited by this paper
• Preoperative nomogram predicting 12-year probability of metastatic renal cancer.

  2008cited by this paper
• Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.

  2008cited by this paper
• Renal mass biopsy--a renaissance?

  2008cited by this paper
• Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors.

  2008cited by this paper
• A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.

  2007cited by this paper
• 5-Year outcomes of laparoscopic partial nephrectomy.

  2007cited by this paper
• Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.

  2007cited by this paper
• 496: Five Year Outcomes of Laparoscopic Partial Nephrectomy

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Rising incidence of small renal masses: a need to reassess treatment effect.

  2007cited by this paper
• Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

  2004cited by this paper
• Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.

  2002cited by this paper
• Natural history of chronic renal insufficiency after partial and radical nephrectomy.

  2002cited by this paper
• Surgical management of renal tumors 4 cm. or less in a contemporary cohort.

  2000cited by this paper
• Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.

  2000cited by this paper
• Rising incidence of renal cell cancer in the United States.

  1999cited by this paper
• Lymphatogenous spread of renal cell carcinoma: an autopsy study.

  1997cited by this paper
• Time trends in the incidence of renal carcinoma: Analysis of connecticut tumor registry data, 1935‐1989

  1994cited by this paper
• Cancer statistics

  1989cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• Ascertainment of vital status through the National Death Index and the Social Security Administration.

  1985cited by this paper

• Retrospective single centre study of microwave ablation in the treatment of cT1 renal cell carcinomas

  2026cites this paper
• A Personalized, Risk-Based Approach to Active Surveillance for Prostate Cancer with Takeaways from Broader Oncology Practices: A Mixed Methods Review

  2025cites this paper
• Non‐surgical management vs active treatment in T1a renal cell carcinoma: a population‐based study

  2025cites this paper
• Tumor necrosis-informed prognostic nomogram for clear cell renal cell carcinoma model development and clinical validation

  2025cites this paper
• Interventionelle Therapie von Nierentumoren

  2025cites this paper
• Cardiovascular Disease and Other Competing Causes of Death in Older Kidney Cancer Patients

  2025cites this paper
• Imaging Biomarkers in Evaluation of Malignancy and Aggressiveness in Renal Masses.

  2025cites this paper
• Outcomes After Initial Noninterventional Management of Clinical Stage cT1b Renal Masses

  2025cites this paper
• Management of Small Renal Masses: Literature and Guidelines Review

  2025cites this paper
• Stereotactic Body Radiotherapy for Renal Cell Carcinoma—A Review of Use in the Primary, Cytoreductive and Oligometastatic Settings

  2024cites this paper
• Stereotactic Body Radiotherapy (SBRT) for the Treatment of Primary Localized Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

  2024cites this paper
• Robot-assisted partial nephrectomy in patients aged 75 years or older – comparing the risk of complications with their younger counterparts

  2024cites this paper
• Robotic partial nephrectomy: Indications, patient selection, and setup for success.

  2024cites this paper
• Simplified cardiovascular index may be the best comorbidity index for clinical use in prediction of mortality for renal cancer patients.

  2024cites this paper
• Oncological Outcomes of Active Surveillance versus Surgery or Ablation for Patients with Small Renal Masses: A Systematic Review and Quantitative Analysis.

  2024cites this paper
• Immunotherapy and stereotactic body radiotherapy for older patients with non-metastatic renal cancer unfit for surgery or decline nephrectomy: practical proposal by the International Geriatric Radiotherapy Group

  2024cites this paper
• The Impact of a Multidisciplinary Tumor Board (MTB) on Treatment Decision Making for Patients With Renal Cell Carcinoma (RCC): 5-Year Data Analysis.

  2024cites this paper
• Crafting and Authenticating Prognostic Nomograms for Overall and Cancer-specific Survival in Pediatric Small Renal Masses: A Comprehensive Two-Decade Cohort Study

  2024cites this paper
• Development and validation of a multicenter Cox regression model to predict all-cause mortality in patients with renal masses suspicious for renal cancer.

  2024cites this paper
• Robot-assisted partial nephrectomy in younger versus older adults with renal cell carcinoma: a propensity score-matched analysis

  2024cites this paper
• Risk factors of surgical compliance and impact on survival in patients with kidney cancer: a population-based, propensity score matching study

  2024cites this paper
• CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model

  2024cites this paper
• Survival benefit stratification of partial nephrectomy versus non‐surgical treatment in elderly patients with T1a renal cell carcinoma

  2023cites this paper
• Optimal management of renal cell carcinoma in octogenarians: Retrospective analysis using updated Korean Renal Cell Carcinoma (KORCC) database

  2023cites this paper
• Geriatric assessment in the older adult with genitourinary cancer: A narrative review

  2023influential citation
• Thermal ablation vs. active surveillance for renal masses: a systematic review and network meta-analysis.

  2023cites this paper
• Prognostic Significance of Advanced Age in Patients with T1a Renal Cell Carcinoma Treated by Microwave Ablation: A 16-Year Experience

  2023cites this paper
• The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma

  2023cites this paper
• TRENDS IN SURGICAL MANAGEMENT OF RENAL NEOPLASMS: SINGLE CENTER RESULTS IN THE LAST DECADE

  2023cites this paper
• Morbidity of elective surgery for localized renal masses among elderly patients: A contemporary multicenter study.

  2023cites this paper
• The national utilization of nonoperative management for small renal masses over 10 years

  2023cites this paper
• Minimal invasive treatment and active surveillance of renal cell carcinoma

  2023cites this paper
• Building a Roadmap for Surveillance of Renal Masses using a modified Delphi Method to help Achieve Consensus.

  2023cites this paper
• Types and characteristics of renal lesions - diagnosis, treatment and prognosis

  2023cites this paper
• The Changing Role of Renal Mass Biopsy.

  2023cites this paper
• Comparison of aggressiveness in central versus peripheral T1a clear-cell renal cell carcinoma.

  2023cites this paper
• Laparoscopic Partial Nephrectomy for Bilateral Complex Renal Masses with High-Score

  2022cites this paper
• A web-based prediction model for overall survival of elderly patients with early renal cell carcinoma: a population-based study

  2022cites this paper
• Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality

  2022cites this paper
• MP50-18 EFFICACY AND FEASIBILITY OF ROBOT-ASSISTED PARTIAL NEPHRECTOMY FOR OCTOGENARIANS: COMPARISON WITH YOUNGER COUNTERPARTS

  2022cites this paper
• Ultrasound Correlates Highly with Cross Sectional Imaging for Small Renal Masses in a Contemporary Cohort.

  2022cites this paper
• Safety, efficacy, and mid-term oncological outcomes of computed tomography-guided cryoablation of T1 renal cancer

  2022cites this paper
• [Results of radiofrequency on small renal masses: Complications, effects on renal fonction and oncological outcomes].

  2022cites this paper
• Applied Change Management in Interventional Radiology—Implementation of Percutaneous Thermal Ablation as an Additional Therapeutic Method for Small Renal Masses

  2022cites this paper
• The changing trends of image-guided biopsy of small renal masses before intervention—an analysis of European multinational prospective EuRECA registry

  2022cites this paper
• The multispeciality approach to the management of localised kidney cancer.

  2022cites this paper
• Diagnosis and Treatment of Small Renal Masses: Where Do We Stand?

  2022cites this paper
• Biomarker-Oriented Therapy in Bladder and Renal Cancer

  2021cites this paper
• Comorbidity and frailty assessment in renal cell carcinoma patients

  2021cites this paper
• Oncological outcomes of active surveillance and percutaneous cryoablation of small renal masses are similar at intermediate term follow-up.

  2021cites this paper
• Available active surveillance follow-up protocols for small renal mass: a systematic review

  2021cites this paper
• Active Surveillance of Small Renal Masses: A Systematic Review

  2021influential citation
• Natural history of Von Hippel–Lindau disease-associated and sporadic clear cell renal cell carcinoma: a comparative study

  2021cites this paper
• Disease Progression in Older Patients With Renal Tumor Assigned to an Active Surveillance Protocol.

  2021cites this paper
• GUIDELINES FOR DIAGNOSTIC AND THERAPEUTIC MANAGEMENT Polish Society of Clinical Oncology and Polish Urological Association Guidelines for the diagnosis and treatment of renal cell cancer

  2021cites this paper
• Surveillance for low-risk kidney cancer: a narrative review of contemporary worldwide practices

  2021influential citation
• ZALECENIA POSTĘPOWANIA DIAGNOSTYCZNO-TERAPEUTYCZNEGO W RAKU NERKOWOKOMÓRKOWYM

  2021cites this paper
• Intermediate‐ and long‐term oncological outcomes of active surveillance for localized renal masses: a systematic review and quantitative analysis

  2021cites this paper
• RENAL MASS AND LOCALIZED RENAL CANCER: EVALUATION, MANAGEMENT, AND FOLLOW-UP: AUA GUIDELINE

  2021cites this paper
• Survival benefits analyses of T1a renal cell carcinoma patients treated with microwave ablation.

  2021cites this paper
• Postoperative outcomes of elderly patients undergoing partial nephrectomy

  2021cites this paper
• Can kidney parenchyma metabolites serve as prognostic biomarkers for long-term kidney function after nephrectomy for renal cell carcinoma? A preliminary study

  2020cites this paper
• Initial Observation of a Large Proportion of Patients Presenting with Clinical Stage T1 Renal Masses: Results from the MUSIC-KIDNEY Statewide Collaborative

  2020cites this paper
• Die unklare Nierenraumforderung: wie weiter?

  2020cites this paper
• [CLINICAL RESULTS OF TWO PATIENTS WITH LATE RECURRENCE OF RENAL CELL CARCINOMA AFTER LONG TERM OBSERVATION WITHOUT TREATMENT].

  2020cites this paper
• Management of the Small Renal Mass: a 2020 Update

  2020cites this paper
• Comparison of renal functional outcomes of active surveillance and partial nephrectomy in the management of oncocytoma

  2020cites this paper
• Asymptomatic Kidney Tumors in Elderly Patients: Review of Treatment Approaches in Russia and Western Countries

  2020cites this paper
• Prognostic Effect of Comorbid Disease and Immune Gene Expression on Mortality in Kidney Cancer—A Population Based Study

  2020cites this paper
• Renal Mass Biopsy: An Evolution and Current Status

  2020cites this paper
• Characteristics and Surgical Outcomes in Very Elderly Patients (≥75 years) with Renal Cell Carcinoma: Data from the Latin American Renal Cancer Group.

  2020cites this paper
• Renal Mass Biopsy: Indications, Risks, Technical Aspects and Future Trends

  2020cites this paper
• Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma.

  2020cites this paper
• Active surveillance for non-muscle invasive bladder cancer

  2019cites this paper
• [Geriatric specificities of localized renal cell carcinoma].

  2019cites this paper
• Treatment of Small Renal Masses

  2019cites this paper
• Use of delayed intervention for small renal masses initially managed with active surveillance.

  2019cites this paper
• Comparison of survival benefits of nephron-sparing intervention or active surveillance for patients with localized renal masses: a systematic review and meta-analysis

  2019influential citation
• Partial nephrectomy vs cryoablation for T1a renal cell carcinoma: A comparison of survival benefit stratified by tumour size.

  2019cites this paper
• Integrated Molecular Analysis for the Identification and Validation of Novel Biomarkers for Renal Cell Carcinoma and the Small Renal Mass

  2019cites this paper
• The Role of Hematological Parameters in Predicting Fuhrman Grade and Tumor Stage in Renal Cell Carcinoma Patients Undergoing Nephrectomy

  2019cites this paper
• Tumor location does not limit percutaneous treatment of small renal masses with microwave ablation.

  2019cites this paper
• Trends in Renal Cancer Incidence Mortality

  2019cites this paper
• An important step in establishing a treatment strategy for small renal masses of clear cell renal cell carcinoma based on the significance of adverse histopathologic features on tumor needle biopsy.

  2019cites this paper
• The role of the renal biopsy and surveillance in the management of small renal masses

  2019cites this paper
• Kidney and Ureter Neoplasm

  2019cites this paper
• Retrospective evaluation of the potential prognostic value of the preoperatively assessed eosinophil granulocyte count regarding clinical outcomes in non-metastatic clear cell renal cell carcinoma patients

  2019cites this paper
• Trends in the treatment of clinical T1 renal cell carcinoma for octogenarians: Analysis of the National Cancer Database.

  2019cites this paper
• National trends and economic impact of surgical treatment for benign kidney tumors.

  2019cites this paper
• Surgical treatment for renal masses in the elderly: analysis of oncological, surgical and functional outcomes

  2019cites this paper
• Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project)

  2019cites this paper
• Lokale Therapie des Nierenzellkarzinoms

  2019cites this paper
• Conditional survival of patients with small renal masses undergoing active surveillance

  2018cites this paper
• Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

  2018cites this paper
• Treatment approaches to small renal masses in patients of advanced age (≥75 years).

  2018cites this paper
• Role of Active Surveillance for Localized Small Renal Masses.

  2018cites this paper
• The relationship of Charlson comorbidity index and postoperative complications in elderly patients after partial or radical nephrectomy

  2018cites this paper
• The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses.

  2018cites this paper
• The Role of Active Surveillance for Small Renal Masses

  2018cites this paper
• Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.

  2018cites this paper